UnitedHealth Group Files 8-K Report

TL;DR

UNH filed an 8-K on 8/20/25, standard disclosure.

AI Summary

On August 20, 2025, UnitedHealth Group Incorporated filed an 8-K report. The filing indicates a Regulation FD Disclosure and is related to the company's ongoing operations and reporting requirements. No specific financial transactions or material events were detailed in the provided excerpt.

Why It Matters

This filing serves as a routine update for investors and regulators, confirming UnitedHealth Group's compliance with reporting standards.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for Regulation FD disclosure, indicating no immediate material adverse events.

Key Players & Entities

• UNITEDHEALTH GROUP INC (company) — Registrant
• August 20, 2025 (date) — Date of report
• 0000731766-25-000239 (document_id) — Accession Number

FAQ

Filing Documents

• unh-20250820.htm (8-K) — 30KB
• 0000731766-25-000239.txt ( ) — 189KB
• unh-20250820.xsd (EX-101.SCH) — 3KB
• unh-20250820_def.xml (EX-101.DEF) — 16KB
• unh-20250820_lab.xml (EX-101.LAB) — 29KB
• unh-20250820_pre.xml (EX-101.PRE) — 17KB
• unh-20250820_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. UnitedHealth Group Board Establishes New Public Responsibility Committee, Appoints New Lead Independent Director, and Refreshes Committee Leadership and Composition UnitedHealth Group today announced updates to its Board of Directors, including the formation of a new Public Responsibility Committee, the appointment of a new lead independent director, and changes to its existing committee leadership and composition. F. William McNabb has been appointed lead independent director, replacing Michele Hooper, who will continue to serve as a director. McNabb has served on the Board of Directors since 2018 and brings expertise in regulatory, finance, and capital markets, having previously served as chairman and chief executive officer of the Vanguard Group. A newly formed Public Responsibility Committee will monitor and oversee financial, regulatory, and reputational risks that may affect the company's operations and mission. Core oversight responsibilities include underwriting and forecasting, regulatory relationships, reputational matters, and mergers and acquisitions. Michele Hooper will serve as chair of the committee and Charles Baker, Timothy Flynn and Paul Garcia will serve as members. The creation of the Public Responsibility Committee is part of the company's continuing commitment to a mission-driven culture of responsibility, integrity and performance. It will provide an additional layer of governance, including enhanced oversight of pricing, operational, regulatory and reputational risks. The committee will coordinate with other board committees in monitoring key risks and intersecting areas of oversight. Additional information can be found in the committee's charter, available on the Company's website. UnitedHealth Group has also refreshed the leadership and membership of its four other committees: Audit and Finance Committee: Timothy Flynn (chair), Charles Baker and Kristen Gil Compensation and Human Resources Commit

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 20, 2025 UNITEDHEALTH GROUP INCORPORATED By: /s/ Kuai H. Leong Kuai H. Leong Senior Deputy General Counsel and Deputy Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR